Pharmalink Extracts

Pharmalink Extracts is a New Zealand-based biotechnology company specializing in the research, development, and manufacture of high-quality marine and botanical extracts. The company is globally recognized for its proprietary supercritical CO2 extraction technology, which it uses to produce bioactive lipid fractions, most notably Lyprinol, a stabilized green-lipped mussel oil. Pharmalink's products are primarily targeted at inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and asthma. The company operates a GMP-certified facility and provides contract manufacturing services for the global nutraceutical and pharmaceutical industries.